$532M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | AVLN Avalyn Pharmaceuticals Inc | 1.7M | — | $55M | 10.4% |
| 2 | JNJ Johnson & Johnson | 138,946 | — | $35M | 6.6% |
| 3 | GILD Gilead Sciences Inc | 269,309 | +64.3% | $34M | 6.4% |
| 4 | BBIO Bridgebio Pharma Inc | 455,041 | +5.3% | $34M | 6.4% |
| 5 | SNDX Syndax Pharmaceuticals Inc | 1.2M | +16.5% | $27M | 5.0% |
| 6 | DFTX Definium Therapeutics Inc | 562,672 | −45.8% | $26M | 5.0% |
| 7 | BMY Bristol-Myers Squibb Co | 412,961 | −1.8% | $24M | 4.5% |
| 8 | PBLS Parabilis Medicines Inc | 824,043 | — | $23M | 4.2% |
| 9 | NTRA Natera Inc | 82,181 | +15.9% | $22M | 4.2% |
| 10 | INCY Incyte Corp | 191,627 | +5.2% | $22M | 4.1% |
| 11 | SEPN Septerna Inc | 536,152 | +82.1% | $18M | 3.4% |
| 12 | MLYS Mineralys Therapeutics Inc | 648,722 | +47.8% | $18M | 3.3% |
| 13 | HTFL Heartflow Inc | 583,055 | +44.5% | $17M | 3.2% |
| 14 | CRVS Corvus Pharmaceuticals Inc | 1.1M | +21.2% | $16M | 3.0% |
| 15 | GPCR Structure Therapeutics Inc | 276,550 | +8.3% | $15M | 2.8% |
| 16 | PTGX Protagonist Therapeutics Inc | 106,799 | — | $13M | 2.5% |
| 17 | IRON Disc Medicine Inc | 159,384 | +29.6% | $12M | 2.2% |
| 18 | EW Edwards Lifesciences Corp | 124,778 | −13.7% | $11M | 2.1% |
| 19 | AXSM Axsome Therapeutics Inc. | 43,182 | — | $11M | 2.0% |
| 20 | RARE Ultragenyx Pharmaceutical In | 316,252 | −62.8% | $11M | 2.0% |
| 21 | KLRA Kailera Therapeutics Inc | 468,750 | — | $10M | 1.9% |
| 22 | KPTIQ Karyopharm Therapeutics Inc | 940,855 | +4.8% | $9M | 1.7% |
| 23 | ODTX Odyssey Therapeutics Inc | 457,839 | — | $9M | 1.6% |
| 24 | ASND Ascendis Pharma A/S | 31,759 | — | $8M | 1.6% |
| 25 | KARD Kardigan Inc | 312,500 | — | $7M | 1.4% |
| 26 | ELDN Eledon Pharmaceuticals Inc | 1.7M | +3.4% | $7M | 1.3% |
| 27 | FDMT 4D Molecular Therapeutics In | 471,254 | — | $6M | 1.2% |
| 28 | MANE Veradermics Inc | 45,856 | −73.6% | $6M | 1.1% |
| 29 | DYN Dyne Therapeutics Inc | 244,929 | −13.4% | $5M | 1.0% |
| 30 | GUTS Fractyl Health Inc | 6.2M | +12.3% | $5M | 0.9% |
| 31 | IMCR Immunocore Hldgs Plc | 148,045 | +75.5% | $5M | 0.9% |
| 32 | DNTH Dianthus Therapeutics Inc | 32,941 | −94.1% | $3M | 0.6% |
| 33 | BBOT Bridgebio Oncology Therapeut | 318,407 | — | $2M | 0.5% |
| 34 | TARA Protara Therapeutics Inc | 520,148 | −10.3% | $2M | 0.4% |
| 35 | HYPR Hyperfine Inc | 1.3M | +0.0% | $2M | 0.3% |
| 36 | ATAIBECKLEY INC Ataibeckley Inc | 196,858 | +0.0% | $1M | 0.2% |
| 37 | MGX Metagenomi Therapeutics Inc | 528,993 | +0.0% | $629,502 | 0.1% |
| 38 | OM Outset Med Inc | 118,279 | +0.0% | $510,965 | 0.1% |
| 39 | FTH Faeth Therapeutics Inc | 14,718 | +0.0% | $367,950 | 0.1% |